Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
After finishing at $1.23 in the prior trading day, ProKidney Corp (NASDAQ: PROK) closed at $1.10, down -10.98%. In other words, the price has decreased by -$10.98 from its previous closing price. On the day, 1.65 million shares were traded.
Ratios:
Our goal is to gain a better understanding of PROK by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 17.09 and its Current Ratio is at 17.09.
On September 10, 2024, Guggenheim started tracking the stock assigning a Buy rating and target price of $6.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 19 ’24 when Weber Darin J. sold 16,412 shares for $2.50 per share. The transaction valued at 41,030 led to the insider holds 103,480 shares of the business.
DARIN J WEBER bought 16,412 shares of PROK for $39,225 on Sep 19 ’24. On Jul 26 ’24, another insider, Weber Darin J., who serves as the Chief Regulatory Officer of the company, sold 826 shares for $2.50 each. As a result, the insider received 2,065 and left with 119,892 shares of the company.
Stock Price History:
Over the past 52 weeks, PROK has reached a high of $4.44, while it has fallen to a 52-week low of $1.21. The 50-Day Moving Average of the stock is -31.84%, while the 200-Day Moving Average is calculated to be -48.67%.
Shares Statistics:
A total of 127.92M shares are outstanding, with a floating share count of 91.91M. Insiders hold about 28.18% of the company’s shares, while institutions hold 44.52% stake in the company.
